or Try an Advanced Search...

    Technical Analysis for SNOA - Sonoma Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 2.91 2.46% 0.07
    SNOA closed up 2.46 percent on Thursday, November 21, 2024, on 85 percent of normal volume. It ran into resistance at its 50 day moving average.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical SNOA trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    20 DMA Support Bullish 0.00%
    Calm After Storm Range Contraction 0.00%
    Fell Below 50 DMA Bearish 2.46%
    Inside Day Range Contraction 2.46%
    Upper Bollinger Band Touch Strength 2.46%
    Oversold Stochastic Weakness 2.46%
    Crossed Above 20 DMA Bullish -7.91%
    Crossed Above 50 DMA Bullish -7.91%
    MACD Bullish Signal Line Cross Bullish -7.91%
    Older End-of-Day Signals for SNOA ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Support about 4 hours ago
    10 DMA Support about 4 hours ago
    50 DMA Resistance about 4 hours ago
    Down 3% about 4 hours ago
    Fell Below Previous Day's Low about 4 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SNOA Chart by TradingView
    Basic chart:

    Profile

    Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Animal Health

    Is SNOA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 11 Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel
    Nov 9 Sonoma Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
    Nov 8 Sonoma Pharmaceuticals GAAP EPS of -$0.59, revenue of $3.6M
    Nov 7 Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results
    Oct 31 Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
    Oct 22 Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada
    Oct 21 Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences
    Sep 19 Sonoma Pharmaceuticals regains compliance with Nasdaq minimum bid price rule
    Sep 19 Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
    Sep 17 Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution
    See more SNOA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.374
    52 Week Low 2.52
    Average Volume 403,445
    200-Day Moving Average 3.82
    50-Day Moving Average 3.05
    20-Day Moving Average 2.82
    10-Day Moving Average 2.78
    Average True Range 0.33
    RSI (14) 51.22
    ADX 24.17
    +DI 34.92
    -DI 14.49
    Chandelier Exit (Long, 3 ATRs) 2.63
    Chandelier Exit (Short, 3 ATRs) 3.53
    Upper Bollinger Bands 3.16
    Lower Bollinger Band 2.49
    Percent B (%b) 0.63
    BandWidth 23.67
    MACD Line -0.06
    MACD Signal Line -0.10
    MACD Histogram 0.0356
    Fundamentals Value
    Market Cap 45.42 Million
    Num Shares 15.6 Million
    EPS -1.48
    Price-to-Earnings (P/E) Ratio -1.97
    Price-to-Sales 0.21
    Price-to-Book 0.44
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.47
    Resistance 3 (R3) 3.46 3.26 3.37
    Resistance 2 (R2) 3.26 3.12 3.27 3.34
    Resistance 1 (R1) 3.09 3.03 3.18 3.10 3.31
    Pivot Point 2.89 2.89 2.94 2.90 2.89
    Support 1 (S1) 2.72 2.75 2.81 2.73 2.51
    Support 2 (S2) 2.52 2.66 2.53 2.48
    Support 3 (S3) 2.35 2.52 2.45
    Support 4 (S4) 2.36